Cochlear implant technology gets a boost as Envoy Medical broadens its European patent rights.
Envoy Medical LLC Makes Strides in Fully Implanted Hearing Device Technology
Envoy Medical LLC, a Minnesota-based company, is making waves in the hearing aid industry with its innovative approach to fully implanted hearing devices. The company has recently announced that it has secured a patent for advanced signal processing technology specifically for middle ear sensors.
The patent, a significant step forward in the development of fully implanted hearing devices, is expected to contribute to the advancement of hearing aid technology in general. This technology is integral to the company's hearing devices, including the Esteem Fully Implanted Active Middle Ear Implant (FI-AMEI) and the investigational Acclaim Cochlear Implant.
The Esteem FI-AMEI is another product offered by Envoy Medical LLC, designed to be implanted in the ear canal. The company is currently collaborating with regulatory authorities and partners to secure approval for this device. Safety information for the Esteem FI-AMEI can be found on the company's website at https://www.envoymedical.com/safety-information.
The fully implanted Acclaim Cochlear Implant, while still investigational and limited by Federal law to investigational use, represents another promising avenue for the company. Both devices are part of Envoy Medical LLC's strategy to improve its hearing device technology.
The patent may lead to improved functionality and performance in fully implanted hearing devices. This could potentially revolutionize the way people with hearing loss experience sound.
Envoy Medical LLC encourages those interested in learning more about its products and the company to visit its website at www.envoymedical.com or follow the company on Twitter, LinkedIn, Facebook, or email. Forward-looking statements regarding the company can be found at https://www.newsfilecorp.com/release/267047.
Additional information about Envoy Medical LLC can be found at the Securities and Exchange Commission's (SEC) website at www.sec.gov. The company is committed to keeping the public informed through the dissemination of press releases on the aforementioned platforms.
Read also:
- Increased measles cases Approaching 1,500 in the United States, with a new case detected in the Chicago metropolitan area.
- An Ear Infection Explained: A Discussion on Otitis Media
- Recommendations by CDC advisers for limiting MMRV vaccine choices in younger children, and forthcoming decision on hepatitis B vaccine restrictions.
- October 16th - Volunteer Workforce Training
